OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preventing dementia by preventing stroke: The Berlin Manifesto
Vladimir Hachinski, Karl M. Einhäupl, Detlev Ganten, et al.
Alzheimer s & Dementia (2019) Vol. 15, Iss. 7, pp. 961-984
Open Access | Times Cited: 263

Showing 1-25 of 263 citing articles:

Immune responses to stroke: mechanisms, modulation, and therapeutic potential
Costantino Iadecola, Marion S. Buckwalter, Josef Anrather
Journal of Clinical Investigation (2020) Vol. 130, Iss. 6, pp. 2777-2788
Open Access | Times Cited: 542

Burden of Neurological Disorders Across the US From 1990-2017
Valery L. Feigin, Theo Vos, Fares Alahdab, et al.
JAMA Neurology (2020) Vol. 78, Iss. 2, pp. 165-165
Open Access | Times Cited: 426

Post-Stroke Cognitive Impairment and Dementia
Natalia S. Rost, Amy Brodtmann, Matthew P. Pase, et al.
Circulation Research (2022) Vol. 130, Iss. 8, pp. 1252-1271
Open Access | Times Cited: 415

Hypertension-induced cognitive impairment: from pathophysiology to public health
Zoltán Ungvári, Péter Tóth, Stefano Tarantini, et al.
Nature Reviews Nephrology (2021) Vol. 17, Iss. 10, pp. 639-654
Open Access | Times Cited: 365

The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis
Theophania Ashleigh, Russell H. Swerdlow, M. Flint Beal
Alzheimer s & Dementia (2022) Vol. 19, Iss. 1, pp. 333-342
Closed Access | Times Cited: 228

Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
Zahinoor Ismail, Sandra E. Black, Richard Camicioli, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 8, pp. 1182-1195
Open Access | Times Cited: 182

Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases
Maddalena Grieco, Alessandra Giorgi, Maria Cristina Gentile, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 170

Prevention of dementia in an ageing world: Evidence and biological rationale
Giulia Grande, Chengxuan Qiu, Laura Fratiglioni
Ageing Research Reviews (2020) Vol. 64, pp. 101045-101045
Open Access | Times Cited: 170

Vascular Cognitive Impairment (VCI)
Tatjana Rundek, Magdalena I. Tolea, Taylor Ariko, et al.
Neurotherapeutics (2021) Vol. 19, Iss. 1, pp. 68-88
Open Access | Times Cited: 165

Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop
Berislav V. Zloković, Rebecca F. Gottesman, Kenneth E. Bernstein, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 12, pp. 1714-1733
Closed Access | Times Cited: 164

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline
Joanne Ryan, Elsdon Storey, Anne M. Murray, et al.
Neurology (2020) Vol. 95, Iss. 3
Open Access | Times Cited: 145

Cognitive impairment in sporadic cerebral small vessel disease: A systematic review and meta‐analysis
Olivia KL Hamilton, Ellen V. Backhouse, Esther Janssen, et al.
Alzheimer s & Dementia (2020) Vol. 17, Iss. 4, pp. 665-685
Open Access | Times Cited: 139

Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management
Maria Clara Zanon Zotin, Lukas Sveikata, Anand Viswanathan, et al.
Current Opinion in Neurology (2021) Vol. 34, Iss. 2, pp. 246-257
Open Access | Times Cited: 130

Consumption of coffee and tea and risk of developing stroke, dementia, and poststroke dementia: A cohort study in the UK Biobank
Yuan Zhang, Hongxi Yang, Shu Li, et al.
PLoS Medicine (2021) Vol. 18, Iss. 11, pp. e1003830-e1003830
Open Access | Times Cited: 130

Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management
Yu‐Yuan Huang, Shi-Dong Chen, Xinyi Leng, et al.
Journal of Alzheimer s Disease (2022) Vol. 86, Iss. 3, pp. 983-999
Closed Access | Times Cited: 116

Vascular contributions to Alzheimer's disease
Laura Eisenmenger, Anthony Peret, Bolanle M. Famakin, et al.
Translational research (2022) Vol. 254, pp. 41-53
Open Access | Times Cited: 72

A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study
Merçé Boada, Oscar L. López, Javier Olazarán, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 10, pp. 1412-1425
Open Access | Times Cited: 108

Prevalence and correlates of mild cognitive impairment among diverse Hispanics/Latinos: Study of Latinos‐Investigation of Neurocognitive Aging results
Héctor M. González, Wassim Tarraf, Neil Schneiderman, et al.
Alzheimer s & Dementia (2019) Vol. 15, Iss. 12, pp. 1507-1515
Open Access | Times Cited: 85

Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study
Natalia S. Rost, James F. Meschia, Rebecca F. Gottesman, et al.
Stroke (2021) Vol. 52, Iss. 8
Open Access | Times Cited: 83

Cilostazol for Secondary Prevention of Stroke and Cognitive Decline
Caroline McHutchison, Gordon W. Blair, Jason P. Appleton, et al.
Stroke (2020) Vol. 51, Iss. 8, pp. 2374-2385
Open Access | Times Cited: 82

Cerebrovascular risk factors impact frontoparietal network integrity and executive function in healthy ageing
Michele Veldsman, Xin-You Tai, Thomas E. Nichols, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 78

Page 1 - Next Page

Scroll to top